<DOC>
	<DOC>NCT01427192</DOC>
	<brief_summary>The purpose of this study is to study the differential short-term effect of nocturnal oxygen, acetazolamide tablets and nocturnal non-invasive positive pressure ventilation on symptoms, exercise capacity and nocturnal breathing disturbances in subjects with pulmonary hypertension and sleep related breathing disorders - Trial with medicinal product</brief_summary>
	<brief_title>Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Inclusion criteria: percapillary pulmonary hypertension diagnosed by right heart catheterisation stable therapy and clinical condition for at least 4 weeks sleep disordered breathing with apnea/hypopnea index &gt; 10 events/h and/or median nocturnal oxygen saturation &lt;90% Exclusion criteria: Pregnancy severe daytime hypoxemia (PaO2 &lt; 7.2 kPA) patients with predominantly obstructive sleep apnea.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Breathing-Related Sleep Disorder</keyword>
	<keyword>Pulmonary Hypertension</keyword>
</DOC>